Alzinova: Follow-up on Aducanumab Advisory Committe Panel
Research Note
2020-11-09
08:30
Redeye gives a new comment as the aducanumab (Biogen) thriller continued on Friday. We will come back with a recorded interview later this week.
AH
Anders Hedlund
Disclosures and disclaimers